Literature DB >> 28124147

The Human Stomach in Health and Disease: Infection Strategies by Helicobacter pylori.

Karen Robinson1, Darren P Letley2, Kazuyo Kaneko2.   

Abstract

Helicobacter pylori is a bacterial pathogen which commonly colonizes the human gastric mucosa from early childhood and persists throughout life. In the vast majority of cases, the infection is asymptomatic. H. pylori is the leading cause of peptic ulcer disease and gastric cancer, however, and these outcomes occur in 10-15% of those infected. Gastric adenocarcinoma is the third most common cause of cancer-associated death, and peptic ulcer disease is a significant cause of morbidity. Disease risk is related to the interplay of numerous bacterial host and environmental factors, many of which influence chronic inflammation and damage to the gastric mucosa. This chapter summarizes what is known about health and disease in H. pylori infection, and highlights the need for additional research in this area.

Entities:  

Keywords:  Gastric cancer; Helicobacter pylori; Inflammation; Mucosal immunity; Peptic ulcer disease

Mesh:

Year:  2017        PMID: 28124147     DOI: 10.1007/978-3-319-50520-6_1

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  10 in total

Review 1.  miRNAs in gastrointestinal diseases: can we effectively deliver RNA-based therapeutics orally?

Authors:  A K M Nawshad Hossian; Gerardo G Mackenzie; George Mattheolabakis
Journal:  Nanomedicine (Lond)       Date:  2019-11-18       Impact factor: 5.307

2.  Determinants of Raft Partitioning of the Helicobacter pylori Pore-Forming Toxin VacA.

Authors:  Krishnan Raghunathan; Nora J Foegeding; Anne M Campbell; Timothy L Cover; Melanie D Ohi; Anne K Kenworthy
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

3.  Genetic polymorphisms of IL-17A rs2275913, rs3748067 and IL-17F rs763780 in gastric cancer risk: evidence from 8124 cases and 9873 controls.

Authors:  Rami M Elshazli; Doaa O Salman; Maha M Kamel; Eman A Toraih; Manal S Fawzy
Journal:  Mol Biol Rep       Date:  2018-06-02       Impact factor: 2.316

Review 4.  Strategies used by helicobacter pylori to establish persistent infection.

Authors:  Amin Talebi Bezmin Abadi
Journal:  World J Gastroenterol       Date:  2017-04-28       Impact factor: 5.742

5.  Overexpression of serine protease HtrA enhances disruption of adherens junctions, paracellular transmigration and type IV secretion of CagA by Helicobacter pylori.

Authors:  Aileen Harrer; Manja Boehm; Steffen Backert; Nicole Tegtmeyer
Journal:  Gut Pathog       Date:  2017-07-25       Impact factor: 4.181

6.  Helicobacter pylori and gastrointestinal and neurological diseases: Study protocol of an umbrella review of systematic reviews and meta-analyses.

Authors:  Baoning Wang; Jing Zhang; Sihan Chen; Mingjiang Bie
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

7.  Network Pharmacology and Molecular Docking Analysis on Pharmacological Mechanisms of Astragalus membranaceus in the Treatment of Gastric Ulcer.

Authors:  Piao Zhou; Rui Zhou; Yao Min; Li-Ping An; Fei Wang; Quan-Yu Du
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-31       Impact factor: 2.629

8.  Extra virgin olive oil inhibits Helicobacter pylori growth in vitro and the development of mice gastric mucosa lesions in vivo.

Authors:  Andrea Celeste Arismendi Sosa; María Laura Mariani; Alba Edith Vega; Alicia Beatriz Penissi
Journal:  Front Microbiol       Date:  2022-08-05       Impact factor: 6.064

9.  An infection-induced oxidation site regulates legumain processing and tumor growth.

Authors:  Yekaterina Kovalyova; Daniel W Bak; Elizabeth M Gordon; Connie Fung; Jennifer H B Shuman; Timothy L Cover; Manuel R Amieva; Eranthie Weerapana; Stavroula K Hatzios
Journal:  Nat Chem Biol       Date:  2022-03-24       Impact factor: 16.174

Review 10.  Morphology of Helicobacter pylori as a result of peptidoglycan and cytoskeleton rearrangements.

Authors:  Paweł Krzyżek; Grażyna Gościniak
Journal:  Prz Gastroenterol       Date:  2018-09-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.